FILTER
LATEST INTERVIEWS
Tim Fernback & Malcolm Bell
LICO ENERGY METALS
LiCo are investing in a lithium resource in the mountains of Chile and intend to use high technology extraction methods.
Jean Wilhelmy & André Viau
FONDS DE SOLIDARITÉ FTQ
Fonds de solidarité FTQ is a development capital fund with a mission to contribute to Québec's economic growth by creating, maintaining or protecting jobs through investment in SMEs in all spheres of activity.
Greg Smith
PRESIDENT, TREK MINING
Trek Mining is developing a strong gold portfolio in both processing and mining.
Dr. Quinton Hennigh
CEO & DIRECTOR, NOVO RESOURCES
Novo Resources, based in Vacouver, is developing Gold assets in Australia, set to begin construction at Beatons Creek in 2018.
Jeff Elliott
MANAGING DIRECTOR, CSA GLOBAL
CSA Global is targeting the Americas to further increase the company’s global reach.
Francis Labonté & Eric Roberge
OWNERS, CEO & CFO, LUXIA INNOVATION
Luxia Innovation (Luxia) specializes in the provision and installation of carpet and other floor covering solutions for commercial and private aircraft.
Javiera Contreras
MINING & METALS MANAGER, EY
EY in Chile generates a tenth of its revenues from the mining industry.
Cynthia Garneau
PRESIDENT, BELL HELICOPTER TEXTRON CANADA
Bell Helicopter is a manufacturer of commercial and military helicopters headquartered in the United States with operations in Mirabel and is counted amongst Québec’s “Big 4” OEMs.
Dominique Anglade
MINISTER OF ECONOMY, SCIENCE AND INNOVATION, GOVERNMENT OF QUÉBEC
The mission of the Ministry of Economy, Science and Innovation of the Government of Québec is to support business growth, entrepreneurship, science, innovation, export trade and investment in the province.
Juan Pablo González Toledo
PRESIDENT, INSTITUTE OF MINING ENGINEERS OF CHILE
The President of Chile’s Institute of Mining Engineers speaks to GBR of the current issues that Chilean engineers are facing.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENTLY PUBLISHED
United States Life Sciences 2023
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
